Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$169,618,607
+$38,811,677 QoQ
Shares Held
141,416
-0.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#288
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Capital Management Group, Inc. holds $673,709,624 across 9 Drug Manufacturers - General names. LLY ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
980,465 | $249,008,696 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
141,416 | $169,618,607 | |
| 3 | AZN |
Astrazeneca PLC
|
608,068 | $115,301,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
652,471 | $83,842,523 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
395,783 | $50,003,224 | |
| 6 | ABBV |
AbbVie Inc.
|
10,043 | $2,527,220 | |
| 7 | NVS |
Novartis AG
|
14,258 | $2,234,513 | |
| 8 | AMGN |
Amgen Inc
|
1,626 | $588,807 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,618,607 | 141,416 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $130,806,930 | 142,217 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $149,614,814 | 139,218 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $106,062,341 | 139,007 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $108,074,818 | 138,641 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $109,324,880 | 132,369 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $85,878,052 | 111,241 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $111,104,849 | 125,409 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $109,331,878 | 120,758 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $90,717,915 | 116,610 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $65,236,908 | 111,914 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $67,174,014 | 125,061 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,483,681 | 124,704 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,745,713 | 115,735 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $48,334,780 | 132,120 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $52,861,581 | 163,481 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $47,071,062 | 145,178 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,767,322 | 121,407 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,104,138 | 119,847 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $41,638,906 | 180,216 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $804,467 | 3,505 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,262,529 | 6,758 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,066,055 | 6,314 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $932,081 | 6,297 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,115,767 | 6,796 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,460,999 | 10,532 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||